News
Publications and Press Releases
September 18, 2025
Corner Therapeutics Appoints Biotech Pioneer John Maraganore as
Strategic Adviser
September 8, 2025
Corner Therapeutics Research Opens Path to Universal, Long-Lasting Flu Vaccine and Signals Promise for Oncology
September 8, 2025
An NLRP3-stimulatory adjuvant improves the immunogenicity of influenza virus vaccines in mice and non-human primates. mBio
June 23, 2025
Corner Therapeutics to Present New Preclinical and Human Data on mRNA-Encoded Immunotherapies at FOCiS 2025
April 25, 2025
Poster Presentation, American Association for Cancer Research
“An mRNA-encoded Adjuvant-enzyme Activates STING to Enhance the Immunogenicity of Vaccines Targeting Human Papillomavirus Positive Cancers”
January 13, 2025
Corner Therapeutics hires innate immunity pioneer Jonathan Kagan as
Distinguished Scientist to drive immunotherapy innovation
November 13, 2024
Poster Presentation, Cold Spring Harbor Laboratory Meeting, Biological Data Science
“A Novel Combination Adjuvant Specifically Targets Dendritic Cell Hyperactivation to Enhance T Cell Responses”
October 20, 2024
Poster Presentation, 17th International Symposium of Dendritic Cells
“A Novel Vaccine Adjuvant Activates NLRP3 Inflammasomes in Living Dendritic Cells to Stimulate Robust T Cell Immunity”
October 20, 2024
Poster Presentation, 17th International Symposium of Dendritic Cells
“Adjuvant That Hyperactivates Dendritic Cells Stimulates Robust T and B Cell Immunity to Influenza Antigens”
April 18, 2024
Corner Therapeutics Announces $54 million Series A funding to pioneer novel vaccines that provide lifelong immunity
April 17, 2024
Poster Presentation, 7th Annual Toll Conference
“A Chemically Stable Adjuvant Hyperactivates Dendritic Cells to Initiate Durable Adaptive Immunity”
November 8, 2023
Corner Therapeutics Announces First Publication on Proprietary mRNA Adjuvant Platform
November 8, 2023
mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines mBio
November 3, 2023
Poster Presentation, 38th Annual SITC Meeting
“A Catalytic Adjuvant to Enhance the T cell and Antibody Immunogenicity of Lipid Nanoparticle Vaccines”
September 12, 2023
Targeting innate immune pathways for cancer immunotherapy
Immunity
April 25, 2023
Corner Therapeutics Appoints Rick Malley, M.D., to serve on Scientific Advisory Board
November 29, 2022
Poster Presentation, Inflammasome Therapeutics Summit 2022
“A Unique Dendritic Cell Activation State Utilizes Inflammasomes to Stimulate Memory T Cell Responses in Humans”
November 8, 2022
Poster Presentation, 37th Annual SITC Meeting
“A Unique Dendritic Cell Activation State Utilizes Inflammasomes to Stimulate Anti-Tumor Immunity in Mice”